Jinoos Yazdany
#164,957
Most Influential Person Now
Researcher
Jinoos Yazdany's AcademicInfluence.com Rankings
Jinoos Yazdanyengineering Degrees
Engineering
#7259
World Rank
#8623
Historical Rank
Cybernetics
#160
World Rank
#166
Historical Rank
Biomedical Engineering
#720
World Rank
#732
Historical Rank
Electrical Engineering
#2250
World Rank
#2356
Historical Rank
Download Badge
Engineering
Jinoos Yazdany's Degrees
- PhD Biomedical Engineering Stanford University
- Masters Biomedical Engineering Stanford University
- Bachelors Electrical Engineering University of California, Berkeley
Why Is Jinoos Yazdany Influential?
(Suggest an Edit or Addition)Jinoos Yazdany's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis (2012) (1149)
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry (2020) (867)
- Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice (2012) (643)
- Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data (2018) (576)
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2021) (446)
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases (2020) (236)
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know (2020) (201)
- Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries (2020) (185)
- Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. (2008) (171)
- Depression, medication adherence, and service utilization in systemic lupus erythematosus. (2009) (168)
- Approaches for estimating minimal clinically important differences in systemic lupus erythematosus (2015) (160)
- Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. (2000) (140)
- Childhood‐onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus (2010) (136)
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry (2021) (131)
- Work dynamics among persons with systemic lupus erythematosus. (2007) (127)
- Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. (2011) (124)
- A quality indicator set for systemic lupus erythematosus. (2009) (123)
- Measuring Hospital Quality Using Pediatric Readmission and Revisit Rates (2013) (122)
- Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis (2019) (113)
- Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. (2008) (104)
- Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. (2008) (102)
- Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality? (2010) (101)
- Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis (2016) (94)
- Brief index of lupus damage: A patient‐reported measure of damage in systemic lupus erythematosus (2011) (91)
- The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic (2020) (91)
- Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus (2015) (88)
- Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question (2013) (87)
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2021) (84)
- Impact of memory impairment on employment status in persons with systemic lupus erythematosus. (2007) (83)
- The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. (2008) (80)
- Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 (2020) (76)
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases (2020) (71)
- Medicaid and access to care among persons with systemic lupus erythematosus. (2007) (65)
- Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study (2010) (65)
- Extraarticular Manifestations of Rheumatoid Arthritis in a Multiethnic Cohort of Predominantly Hispanic and Asian Patients (2013) (63)
- Disability in valued life activities among individuals with systemic lupus erythematosus. (2008) (63)
- Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. (2007) (63)
- Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. (2015) (62)
- Using the center for epidemiologic studies depression scale to screen for depression in systemic lupus erythematosus (2011) (59)
- Identification of Risk Factors for Elevated Transaminases in Methotrexate Users Through an Electronic Health Record (2014) (59)
- The role of CD40 ligand in systemic lupus erythematosus (2004) (58)
- Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence (2017) (57)
- Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus (2022) (57)
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 (2021) (57)
- Obesity and its measurement in a community‐based sample of women with systemic lupus erythematosus (2011) (56)
- Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions. (2009) (55)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al (2021) (55)
- Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus (2012) (53)
- Thirty‐Day Hospital Readmissions in Systemic Lupus Erythematosus: Predictors and Hospital‐ and State‐Level Variation (2014) (53)
- Rheumatology Informatics System for Effectiveness: A National Informatics‐Enabled Registry for Quality Improvement (2016) (51)
- Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. (2012) (50)
- Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators (2010) (49)
- Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel (2020) (49)
- Coverage for High‐Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D (2015) (49)
- Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry (2020) (48)
- Revisit Rates and Associated Costs After an Emergency Department Encounter (2015) (47)
- COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations (2022) (47)
- Sex differences in assessment of obesity in rheumatoid arthritis (2013) (46)
- Health‐related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus‐Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L‐QoL) (2011) (46)
- Quality of Care for Incident Lupus Nephritis Among Medicaid Beneficiaries in the United States (2014) (45)
- Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures (2016) (44)
- Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus (2012) (44)
- Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. (2009) (44)
- Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. (2017) (44)
- Defining quality of care in rheumatology: The American College of Rheumatology white paper on quality measurement (2011) (43)
- Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases. (2020) (42)
- Cardiovascular and disease‐related predictors of depression in systemic lupus erythematosus (2011) (42)
- 2019 American College of Rheumatology Reproductive Health in Rheumatic and Musculoskeletal Diseases Guideline. (2020) (42)
- Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus (2012) (41)
- Six refractory lupus patients treated with rituximab: a case series. (2007) (41)
- Quality of Care in Systemic Lupus Erythematosus: Application of Quality Measures to Understand Gaps in Care (2012) (39)
- Hydroxychloroquine treatment in a community‐based cohort of patients with systemic lupus erythematosus (2010) (38)
- Impact of obesity on functioning among women with systemic lupus erythematosus (2011) (38)
- Muscle Strength, Muscle Mass, and Physical Disability in Women With Systemic Lupus Erythematosus (2015) (37)
- Health-related quality of life and employment among persons with systemic lupus erythematosus. (2010) (37)
- Obesity is Independently Associated With Worse Patient‐Reported Outcomes in Women with Systemic Lupus Erythematosus (2019) (36)
- Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project (2020) (36)
- The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance (2020) (36)
- National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia (2016) (35)
- Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study. (2011) (35)
- Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus (2016) (35)
- Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study (2014) (35)
- A Population‐Based Study of Infection‐Related Hospital Mortality in Patients With Dermatomyositis/Polymyositis (2015) (34)
- 2019 American College of Rheumatology Recommended Patient‐Reported Functional Status Assessment Measures in Rheumatoid Arthritis (2019) (34)
- Efficiency Gains for Rheumatology Consultation Using a Novel Electronic Referral System in a Safety‐Net Health Setting (2015) (34)
- Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry (2022) (34)
- Validity of a Self‐Administered Version of the Brief Index of Lupus Damage in a Predominantly African American Systemic Lupus Erythematosus Cohort (2014) (33)
- A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in Systemic Lupus Erythematosus (2017) (33)
- Bone health in systemic lupus erythematosus (2009) (32)
- Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP). (2019) (31)
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases (2021) (31)
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases (2021) (31)
- Relationship Between Poverty and Mortality in Systemic Lupus Erythematosus (2018) (30)
- Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. (2010) (30)
- Quality of care in the rheumatic diseases: current status and future directions (2008) (30)
- Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D (2018) (30)
- The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice (2020) (29)
- A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus (2019) (29)
- Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus (2012) (29)
- Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance (2022) (29)
- Patient-reported outcome measures for use in clinical trials of SLE: a review (2018) (29)
- Poverty, Neighborhoods, Persistent Stress, and Systemic Lupus Erythematosus Outcomes: A Qualitative Study of the Patients’ Perspective (2019) (29)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al (2021) (28)
- "Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes. (2019) (28)
- Automated and flexible identification of complex disease: building a model for systemic lupus erythematosus using noisy labeling (2018) (28)
- Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis (2020) (26)
- Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. (2019) (26)
- Frequent use of the emergency department among persons with systemic lupus erythematosus (2010) (26)
- Validity and Responsiveness of a 10‐Item Patient‐Reported Measure of Physical Function in a Rheumatoid Arthritis Clinic Population (2017) (26)
- Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. (2014) (25)
- American College of Rheumatology White Paper on Performance Outcome Measures in Rheumatology (2016) (25)
- Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials (2019) (25)
- Is frailty a relevant concept in SLE? (2017) (24)
- Longitudinal Validation of the Brief Index of Lupus Damage (2014) (24)
- Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study (2021) (23)
- Protected Health Information filter (Philter): accurately and securely de-identifying free-text clinical notes (2020) (23)
- Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient‐Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus (2019) (23)
- Capturing Patient‐Reported Outcomes During the COVID‐19 Pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience Survey (2020) (23)
- Post-marketing experiences with belimumab in the treatment of SLE patients. (2014) (23)
- Educational and Vocational Outcomes of Adults With Childhood‐ and Adult‐Onset Systemic Lupus Erythematosus: Nine Years of Followup (2014) (22)
- Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus. (2019) (22)
- Who receives contraception counseling when starting new lupus medications? The potential roles of race, ethnicity, disease activity, and quality of communication (2016) (21)
- Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? (2018) (21)
- Relationships Between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus (2020) (21)
- SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry (2022) (20)
- Inflammatory arthritis in patients with COVID-19 (2021) (20)
- Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis (2018) (20)
- Healthcare quality in systemic lupus erythematosus: using Donabedian's conceptual framework to understand what we know. (2012) (20)
- Factors associated with access to rheumatologists for Medicare patients. (2016) (19)
- Impact of Limited Health Literacy on Patient‐Reported Outcomes in Systemic Lupus Erythematosus (2020) (19)
- Medicare Part D Plans’ Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease (2017) (19)
- Interactions Between Patients, Providers, and Health Systems and Technical Quality of Care (2015) (19)
- Characteristics associated with Covid-19 in patients with Rheumatic Disease in Latin America: data from the Covid-19 Global Rheumatology Alliance physician-reported registry (2020) (19)
- Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus (2015) (19)
- Preventing Hepatitis B reactivation in immunosuppressed patients: Is it time to revisit the guidelines? (2010) (19)
- Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus. (2007) (19)
- Using Health Information Technology to Support Use of Patient-Reported Outcomes in Rheumatology. (2019) (18)
- Socioeconomic Disparities in Functional Status in a National Sample of Patients With Rheumatoid Arthritis (2021) (18)
- Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique (2015) (18)
- A new era of quality measurement in rheumatology: electronic clinical quality measures and national registries (2017) (17)
- Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus (2010) (17)
- Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient‐Reported Outcomes in Rheumatoid Arthritis (2016) (17)
- Type I interferon, anti-interferon antibodies, and COVID-19 (2021) (17)
- Mapping Perceptions of Lupus Medication Decision‐Making Facilitators: The Importance of Patient Context (2016) (17)
- Major Depression and Adverse Patient‐Reported Outcomes in Systemic Lupus Erythematosus: Results From a Prospective Longitudinal Cohort (2020) (17)
- Systematic review of the literature informing the systemic lupus erythematosus indicators project: Reproductive health care quality indicators (2011) (17)
- Sex Differences in Health Care Utilization, End‐Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis (2018) (16)
- Protected Health Information filter (Philter): accurately and securely de-identifying free-text clinical notes. (2020) (16)
- Leveraging the electronic health record to improve quality and safety in rheumatology (2017) (16)
- Psychometric Evaluation of the National Institutes of Health Patient‐Reported Outcomes Measurement Information System in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort (2019) (16)
- Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial (2019) (15)
- Mortality Among Hospitalized Individuals With Systemic Lupus Erythematosus in the US Between 2006 and 2016 (2020) (15)
- Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures (2016) (15)
- Receipt of Glucocorticoid Monotherapy Among Medicare Beneficiaries With Rheumatoid Arthritis (2014) (15)
- COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2022) (15)
- Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures (2021) (14)
- Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry (2020) (14)
- Smoking Is Associated with Higher Disease Activity in Rheumatoid Arthritis: A Longitudinal Study Controlling for Time-varying Covariates (2018) (14)
- Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study (2021) (14)
- Drug monitoring in systemic lupus erythematosus: a systematic review. (2011) (14)
- The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States. (2020) (14)
- Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study (2018) (14)
- Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic (2015) (14)
- Patient and clinician perspectives on a patient‐facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis (2020) (14)
- Patterns of Disease‐Modifying Antirheumatic Drug Use in Rheumatoid Arthritis Patients After 2002: A Systematic Review (2013) (14)
- Development of a Set of Lupus‐Specific, Ambulatory Care–Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study (2019) (13)
- RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs. (2020) (13)
- Use and Spending for Biologic Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries (2015) (13)
- Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study (2016) (13)
- Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2022) (13)
- Association of Sweet's Syndrome and Systemic Lupus Erythematosus (2011) (13)
- Differentiating between UCTD and early-stage SLE: from definitions to clinical approach (2021) (13)
- Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making (2015) (12)
- Challenges and Opportunities in Using Patient-reported Outcomes in Quality Measurement in Rheumatology. (2016) (11)
- Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance (2020) (11)
- Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab (2017) (11)
- Failure to Launch: Biosimilar Sales Continue to Fall Flat in the United States (2020) (11)
- Conducting research in a pandemic: The power of social media. (2020) (10)
- Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al (2020) (10)
- Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis (2018) (10)
- Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study (2018) (10)
- Rheumatology Informatics System for Effectiveness (RISE) Practices See Significant Gains in Rheumatoid Arthritis Quality Measures. (2020) (10)
- COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance (2021) (10)
- Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry (2021) (9)
- Effects of Language, Insurance, and Race/Ethnicity on Measurement Properties of the PROMIS Physical Function Short Form 10a in Rheumatoid Arthritis (2019) (9)
- Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (2017) (9)
- Definition and Classification of Lupus and Lupus-Related Disorders (2019) (8)
- Increased Risk of Ischemic Stroke in Systemic Sclerosis: A National Cohort Study of US Veterans (2020) (8)
- Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System (2015) (8)
- Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic (2016) (8)
- COVID‐19 in Rheumatic Diseases: A Research Agenda (2020) (8)
- Race, Ethnicity, and Disparities in Rheumatology Educational Materials (2021) (7)
- Three Quality Improvement Initiatives and Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results From an Interrupted Time Series Study (2020) (7)
- Rheumatoid arthritis quality measures and radiographic progression. (2014) (7)
- Influence of Continuing Medical Education on Rheumatologists’ Performance on National Quality Measures for Rheumatoid Arthritis (2015) (7)
- Chapter 1 – Definition and Classification of Lupus and Lupus-Related Disorders (2013) (7)
- Systematic Review and Appraisal of the Cross‐Cultural Validity of Functional Status Assessment Measures in Rheumatoid Arthritis (2020) (6)
- Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. (2019) (6)
- Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Health Care Settings (2020) (6)
- High Disease Severity Among Asian Patients in a US Multiethnic Cohort of Individuals With Systemic Lupus Erythematosus (2020) (5)
- Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus. (2020) (5)
- OP0068 Practices participating in the ACR'S rheumatology informatics system for effectiveness (RISE) national registry show improvements in quality of care (2017) (5)
- Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons — California, 2007–2017 (2021) (5)
- Accurate Measurement In California's Safety-Net Health Systems Has Gaps And Barriers. (2018) (5)
- The Evolving Art and Science of American College of Rheumatology Guidelines (2018) (5)
- Quality improvement initiatives in rheumatology: an integrative review of the last 5 years (2019) (5)
- Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al (2021) (4)
- Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study (2022) (4)
- OP0006 ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (2021) (4)
- Quality of Care for Patients With Systemic Lupus Erythematosus: Data From the American College of Rheumatology RISE Registry (2020) (4)
- Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data (2021) (4)
- Treatment of Sarcoidosis in US Rheumatology Practices: Data From the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry (2020) (4)
- The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient‐Reported Outcome Collection and Patient‐Centered Communication in Adult Rheumatology (2021) (4)
- Underestimation of the Reliability of Codes for Rheumatoid Arthritis Within Administrative Data: Comment on the Article by Ng et al (2013) (3)
- Physical Inactivity Independently Predicts Incident Depression in a Multi-Racial/Ethnic Systemic Lupus Cohort. (2021) (3)
- Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate (2016) (3)
- FRI0577 A National Electronic Health Record-Enabled Registry in Rheumatology: The Acr's Rheumatology Informatics System for Effectiveness (RISE) (2016) (3)
- Significant Gains in Rheumatoid Arthritis Quality Measures Among RISE Registry Practices (2022) (3)
- Race, Ethnicity, and Disparities in the Risk of End‐Organ Lupus Manifestations Following a Systemic Lupus Erythematosus Diagnosis in a Multiethnic Cohort (2022) (3)
- A168: Systemic Lupus Erythematosus In‐Hospital Mortality Risk Across Ages: A National Estimate (2014) (3)
- Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2022) (3)
- The Relationship Between Electronic Health Record System and Performance on Quality Measures in the American College of Rheumatology’s Rheumatology Informatics System for Effectiveness (RISE) Registry: Observational Study (2021) (3)
- Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry (2022) (3)
- Clinical problem-solving. The heart of the matter. (2013) (3)
- Variations in Radiographic Procedure Use for Medicare Patients With Rheumatoid Arthritis (2017) (3)
- Further Lessons in Pneumocystis Pneumonia Prophylaxis. (2018) (3)
- Review of publications evaluating opioid use in patients with inflammatory rheumatic disease. (2022) (2)
- Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus (2020) (2)
- OP0263 HYDROXYCHLOROQUINE DOSING IN PATIENTS WITH RHEUMATIC DISEASE ACROSS THE U.S.: DATA FROM THE RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENESS (RISE) REGISTRY (2019) (2)
- Predictors of Thirty‐Day Hospital Readmissions in Systemic Lupus Erythematosus in the United States: A Nationwide Study (2022) (2)
- Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study. (2020) (2)
- Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status. (2022) (2)
- Using Process Improvement and Systems Redesign to Improve Rheumatology Care Quality in a Safety Net Clinic (2020) (2)
- Racial and ethnic differences in COVID-19 outcomes: a call to action (2022) (2)
- FRI0249 THE RISK OF VENOUS THROMBOEMBOLIC EVENTS IN ADULT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW AND META-ANALYSIS (2019) (2)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers (2021) (2)
- SAT0194 EVALUATION OF PSYCHOMETRIC PROPERTIES OF THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) PHYSICAL FUNCTION 10-ITEM SHORT FORM IN SYSTEMIC LUPUS ERYTHEMATOSUS (2019) (2)
- Dynamics of Methylation of CpG Sites Associated With Systemic Lupus Erythematosus Subtypes in a Longitudinal Cohort (2022) (2)
- Response to: ‘Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al (2020) (2)
- Strategies for Preventive Care in Systemic Lupus Erythematosus (2008) (2)
- Epidemiology and treatment of Behçet’s disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions (2021) (2)
- Evaluating the Use of Glucocorticoids Among Belimumab‐Treated Patients With Systemic Lupus Erythematosus in Real‐World Settings Using the Rheumatology Informatics System for Effectiveness Registry (2022) (2)
- Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis (2014) (2)
- Improving Patient Safety in Public Hospitals: Developing Standard Measures to Track Medical Errors and Process Breakdowns (2018) (2)
- 187 Application of text mining methods to identify lupus nephritis from electronic health records (2019) (2)
- THU0600 Cumulative adverse childhood experiences are associated with poor outcomes in adults with systemic lupus erythematosus (2017) (2)
- The racial/ethnic and sociocultural aspects of the pandemic in rheumatology (2021) (2)
- Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseases. (2022) (2)
- Using medicare data to understand health care value--reply. (2015) (1)
- Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry (2022) (1)
- Practical Considerations for Developing Clinical Natural Language Processing Systems for Population Health Management and Measurement (2022) (1)
- 213 Association between age of SLE diagnosis and disease damage differs across racial/ethnic groups: results from the california lupus epidemiology study (2019) (1)
- Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry) (2022) (1)
- The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding (2018) (1)
- Rapid Adoption of Telemedicine in Rheumatology Care During the COVID‐19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees (2021) (1)
- Reimagining Rheumatology: Big Data and the Future of Clinical Practice and Research (2020) (1)
- Clinical Practice Guidelines and Diagnostic Uncertainty in the Management of Early Rheumatoid Arthritis (2009) (1)
- The impact of COVID-19 on rheumatology training—results from the COVID-19 Global Rheumatology Alliance trainee survey (2022) (1)
- OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA) (2021) (1)
- OP0117 REAL-WORLD EFFECTIVENESS OF TNFI VERSUS NON-TNFI BIOLOGICS ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE ACR’S RISE REGISTRY (2021) (1)
- Reply (2017) (1)
- Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life? (2022) (1)
- Differences in Longitudinal Disease Activity Between Research Cohort and Noncohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data (2019) (1)
- S855 Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Conditions Treated With Systemic Immunosuppressive Therapies: A Population-Based Study (2021) (0)
- Title Coverage for high-cost specialty drugs for rheumatoid arthritis in medicare part D Permalink (2015) (0)
- FRI0711 Discordance of the framingham cardiovascular risk score and the 2013 american college of cardiology/american heart association risk score in systemic lupus erythematosus and rheumatoid arthritis (2017) (0)
- Reply (2012) (0)
- THU0651 AN INDIVIDUALIZED DECISION-AID FOR DIVERSE WOMEN WITH LUPUS NEPHRITIS (IDEA-WON): A RANDOMIZED CONTROLLED TRIAL (2019) (0)
- Title Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic Permalink (2016) (0)
- OP0312 VARIABILITY IN BIOLOGIC PRESCRIPTION PATTERNS FOR RHEUMATOID ARTHRITIS PATIENTS IN THE AMERICAN COLLEGE OF RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENESS (RISE) REGISTRY (2019) (0)
- 61 Differences in organ system involvement across racial/ethnic groups: results from the california lupus epidemiology study (2019) (0)
- Reply (2013) (0)
- Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment. (2020) (0)
- Shifting knowledge and attitudes about biosimilars among rheumatologists. (2020) (0)
- Physical Inactivity and Incident Depression in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort (2022) (0)
- Country-Level Factors Associated With COVID-19-Related Death in People With Rheumatic Disease: Results From the COVID-19 Global Rheumatology Alliance Registry (2022) (0)
- Perceived Stress Independently Predicts Worse Disease Activity and Symptoms in a Multi-Racial/Ethnic Systemic Lupus Cohort. (2022) (0)
- FRI0524 THE ACR’S RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENESS (RISE) REGISTRY SUPPORTS SMALL RHEUMATOLOGY PRACTICES FOR FEDERAL QUALITY REPORTING PROGRAM (2020) (0)
- AB1087 Poverty, poor neighborhoods, and sle outcomes: the patient's perspective (2017) (0)
- GG-06 Integrative analysis of multi-omics data in an ethnically diverse lupus cohort identifies distinct molecular subtypes of SLE (2018) (0)
- In reply: Using medicare data to understand health care value: Measures of incremental cost and effectiveness are both needed to estimate value (2015) (0)
- Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus (2020) (0)
- 58 Identification of systemic lupus erythematosus subgroups using electronic health record and genetic databases (2018) (0)
- A Personalized Decision Aid to Help Women with Lupus Nephritis from Racially and Ethnically Diverse Backgrounds Make Decisions about Taking Immune-Blocking Medicines (2019) (0)
- Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus (2023) (0)
- MEDICARE PART D—COST BURDEN OF INHALED DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017) (0)
- Usual source of care and geographic region are largest predictors of healthcare quality for incident lupus nephritis in US Medicaid recipients (2012) (0)
- THU0445 Are Patient Ratings of Providers and Health Plans Associated with Technical Quality of Care in Sle? (2014) (0)
- Are patient ratings of interactions with providers and health plans associated with technical quality of care in systemic lupus erythematosus? (2014) (0)
- 1602 Switching from mycophenolate mofetil to mycophenolic acid in SLE patients: Results from the RISE registry (2022) (0)
- 257 Residential exposures are associated with increased odds of SLE diagnosis (2019) (0)
- THU0630 THE ACR’S RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENESS (RISE) DEMONSTRATES IMPROVEMENTS IN MANY MEASURES OF QUALITY OF CARE BETWEEN 2016 AND 2017 (2019) (0)
- EF-02 Longitudinal study of long-term poverty and persistent depressive symptoms in SLE (2018) (0)
- CE-11 Epidemiologic evidence for the effect of poverty on SLE damage: a longitudinal study (2016) (0)
- Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE (2014) (0)
- Capturing Heterogeneity in Complex Chronic Illness: Building a Model for Systemic Lupus Erythematosus (SLE) with "Noisy Labeling" of Data (2018) (0)
- Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (2017) (0)
- Ethnicity-specific transcriptomic variation in immune cells and correlation with disease activity in systemic lupus erythematosus (2020) (0)
- The Relationship Between Electronic Health Record System and Performance on Quality Measures in the American College of Rheumatology’s Rheumatology Informatics System for Effectiveness (RISE) Registry: Observational Study (Preprint) (2021) (0)
- BD-06 Identification of systemic lupus erythematosus subgroups using electronic health record and genetic databases (2018) (0)
- OP0288 MACHINE LEARNING ALGORITHMS TO PREDICT COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES: RESULTS FROM THE GLOBAL RHEUMATOLOGY ALLIANCE PROVIDER REGISTRY (2021) (0)
- OP0325 Effect of three health it interventions on ra disease activity score documentation in an academic rheumatology clinic (2018) (0)
- Monitoring and achievement of target serum urate among gout patients receiving long-term urate lowering therapy in the ACR's RISE Registry. (2022) (0)
- AB0674 RAPID ADOPTION OF TELEMEDICINE IN RHEUMATOLOGY TRAINING: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE TRAINEE SURVEY (2021) (0)
- Behind ACR's Challenge to Choose Tests Wisely (2013) (0)
- CE-13 Is frailty a relevant concept in lupus? (2016) (0)
- Reply (2019) (0)
- POS0051 THE IMPACT OF COVID-19 ON RHEUMATOLOGY TRAINING: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE TRAINEE SURVEY (2021) (0)
- Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures (2021) (0)
- FRI0556 Does Leaving Poverty Reduce Newly Accumulated Damage in SLE? (2016) (0)
- Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance (2022) (0)
- CE-50 Novel informatics approaches to automate case-identification of lupus in an electronic health record (2016) (0)
- Area-level socioeconomic status and variation in medication use among Medicaid enrollees with incident systemic lupus erythematosus, 2000 to 2004 (2012) (0)
- 202 Causes of death among populations with systemic lupus erythematosus by sex, race and ethnicity (2021) (0)
- The racial/ethnic and sociocultural aspects of the pandemic in rheumatology Best Practice & Research Clinical Rheumatology (0)
- 149 Network-based analysis of clinical and molecular data in a multiethnic lupus cohort identifies molecular associations with serological manifestations (2019) (0)
- 108 Evaluation of psychometric properties of the patient-reported outcomes measurement information system physical function 10-item short form in systemic lupus erythematosus (2019) (0)
- OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES (2022) (0)
- Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023) (0)
- List of Contributors (2019) (0)
- CE-04 Sex differences in healthcare utilisation, end-stage renal disease and mortality among U.S. medicaid beneficiaries with incident lupus nephritis (2016) (0)
- Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies. (2023) (0)
- OP0201 Clinical outcomes and response to anti-thrombotic treatment among patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicenter cohort study (2018) (0)
- University of Southern Denmark Three Quality Improvement Initiatives and Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records (2019) (0)
- POS0195 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS HAVE AN INCREASED RISK OF MORTALITY, MECHANICAL VENTILATION, AND HOSPITALIZATION FROM COVID-19 (2022) (0)
- 606 Cell-specific human endogenous retrovirus expression, host gene expression and SLE phenotypes (2022) (0)
- Cardiovascular Disease Disparities in Systemic Lupus Erythematosus (2022) (0)
- The association of trauma with self-reported flares and disease activity in systemic lupus erythematosus (SLE). (2022) (0)
- Natural Language Processing Tool for Extraction of Patient-reported Outcomes from a National Multi-EHR Registry (2021) (0)
- Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis (2023) (0)
- Causes of Death Among Individuals With Systemic Lupus Erythematosus by Race and Ethnicity: A Population‐Based Study (2022) (0)
- Comment on "Quality indicators for psoriatic arthritis". (2008) (0)
- Reply: To PMID 22556106. (2013) (0)
- Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus (2022) (0)
- Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry (2023) (0)
- Hepatitis B Screening Before Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug Therapy: Many Roads to Improvement (2021) (0)
- Response to Dr. Giannouli (2016) (0)
- THU0647 Longitudinal study of long-term poverty and persistent depressive symptoms in sle (2018) (0)
- articleProvision of preventive health care in systemic lupus erythematosus : data from a large observational cohort study (2015) (0)
- Additional file 5: of Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making (2015) (0)
- Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jinoos Yazdany?
Jinoos Yazdany is affiliated with the following schools:
